U.S. License Holder:
EMD Serono
Date of License:
May-25-2004
Last Update:
Dec-15-2024
FDA-Approved Indications
GONAL-F RFF REDI-JECT (follitropin alfa for injection) is a prefilled gonadotropin-containing auto-injection device indicated for:
Induction of ovulation and pregnancy in oligo-anovulatory women in whom the cause of infertility is functional and not due to primary ovarian failure;
Development of multiple follicles in ovulatory women as part of an Assisted Reproductive Technology (ART) cycle.